Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam J Walker

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Acta Neuropsychiatrica|December 23, 2021
Exploring interleukin-6, lipopolysaccharide-binding protein and brain-derived neurotrophic factor following 12 weeks of adjunctive minocycline treatment for depressionKyoko Hasebe, Mohammadreza Mohebbi, Laura Gray, et al.
International Journal of Molecular Sciences|March 29, 2023
Minocycline as Treatment for Psychiatric and Neurological Conditions: A Systematic Review and Meta-AnalysisBruna Panizzutti, David Skvarc, Sylvia Lin, et al.
Neuroscience and Biobehavioral Reviews|July 15, 2021
Statins: Neurobiological underpinnings and mechanisms in mood disordersAdam J Walker, Yesul Kim, Igor Borissiouk, et al.
Frontiers in Psychiatry|July 2, 2021
The Effect of Adjunctive Mangosteen Pericarp on Cognition in People With Schizophrenia: Secondary Analysis of a Randomized Controlled TrialWolfgang Marx, David R Skvarc, Mohammadreza Mohebbi, et al.
Biochemical Pharmacology|May 7, 2024
Neuroanatomical distribution of fluorophores within adult RXFP3 Cre-tdTomato/YFP mouse brainIzel M Eraslan, Monique Egberts-Brugman, Justin L Read, et al.
Frontiers in Psychiatry|March 29, 2019
The Therapeutic Potential of Mangosteen Pericarp as an Adjunctive Therapy for Bipolar Disorder and SchizophreniaMelanie M Ashton, Olivia M Dean, Adam J Walker, et al.
The Australian and New Zealand Journal of Psychiatry|October 23, 2020
Minocycline as adjunctive treatment for major depressive disorder: Pooled data from two randomized controlled trialsRobson Zazula, Muhammad Ishrat Husain, Mohammadreza Mohebbi, et al.
Molecular Psychiatry|November 24, 2020
The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studiesWolfgang Marx, Amelia J McGuinness, Tetyana Rocks, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|September 15, 2023
Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and managementMichael Berk, Ole Köhler-Forsberg, Megan Turner, et al.
The British Journal of Psychiatry : the Journal of Mental Science|July 10, 2025
The efficacy of adjunctive <i>Garcinia mangostana</i> Linn. (mangosteen) pericarp extract for bipolar depression: 24-week randomised controlled trialOlivia M Dean, Susan M Cotton, Melanie M Ashton, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Acta Neuropsychiatrica|December 23, 2021
Exploring interleukin-6, lipopolysaccharide-binding protein and brain-derived neurotrophic factor following 12 weeks of adjunctive minocycline treatment for depressionKyoko Hasebe, Mohammadreza Mohebbi, Laura Gray, et al.
International Journal of Molecular Sciences|March 29, 2023
Minocycline as Treatment for Psychiatric and Neurological Conditions: A Systematic Review and Meta-AnalysisBruna Panizzutti, David Skvarc, Sylvia Lin, et al.
Neuroscience and Biobehavioral Reviews|July 15, 2021
Statins: Neurobiological underpinnings and mechanisms in mood disordersAdam J Walker, Yesul Kim, Igor Borissiouk, et al.
Frontiers in Psychiatry|July 2, 2021
The Effect of Adjunctive Mangosteen Pericarp on Cognition in People With Schizophrenia: Secondary Analysis of a Randomized Controlled TrialWolfgang Marx, David R Skvarc, Mohammadreza Mohebbi, et al.
Biochemical Pharmacology|May 7, 2024
Neuroanatomical distribution of fluorophores within adult RXFP3 Cre-tdTomato/YFP mouse brainIzel M Eraslan, Monique Egberts-Brugman, Justin L Read, et al.
Frontiers in Psychiatry|March 29, 2019
The Therapeutic Potential of Mangosteen Pericarp as an Adjunctive Therapy for Bipolar Disorder and SchizophreniaMelanie M Ashton, Olivia M Dean, Adam J Walker, et al.
The Australian and New Zealand Journal of Psychiatry|October 23, 2020
Minocycline as adjunctive treatment for major depressive disorder: Pooled data from two randomized controlled trialsRobson Zazula, Muhammad Ishrat Husain, Mohammadreza Mohebbi, et al.
Molecular Psychiatry|November 24, 2020
The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studiesWolfgang Marx, Amelia J McGuinness, Tetyana Rocks, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|September 15, 2023
Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and managementMichael Berk, Ole Köhler-Forsberg, Megan Turner, et al.
The British Journal of Psychiatry : the Journal of Mental Science|July 10, 2025
The efficacy of adjunctive <i>Garcinia mangostana</i> Linn. (mangosteen) pericarp extract for bipolar depression: 24-week randomised controlled trialOlivia M Dean, Susan M Cotton, Melanie M Ashton, et al.
Pageof 6